MarketCap
Facebook
X
TelegramCerecor Inc. Finanzkreislauf | CERC
Finanzkreislauf Jährlich Cerecor Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.98 | 25.8 | 8.35 | 7.81 | 11.2 | 13.3 | 13.5 | 12.8 | -5.66 | 15.5 | 44.9 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 44.9 | -5.66 | 13.6 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Vascular Biogenics Ltd.
VBLT
|
-2.21 K | - | -8.77 % | $ 12.4 M |  Israel |
 |
Histogen
HSTO
|
12.8 | - | 31.6 % | $ 2.12 M |  USA |
 |
Summit Therapeutics
SMMT
|
-84.8 K | $ 16.64 | -6.7 % | $ 12.4 B |  Britain |
 |
Cidara Therapeutics
CDTX
|
2.26 K | - | - | $ 1.41 B | USA |
 |
Syndax Pharmaceuticals
SNDX
|
48.3 | $ 9.59 | 1.05 % | $ 831 M | USA |
 |
Clovis Oncology
CLVS
|
271 | - | -7.23 % | $ 13 M | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
402 | - | - | $ 1.62 B | Israel |
 |
Bio-Techne Corporation
TECH
|
210 | $ 72.8 | -0.03 % | $ 11.4 B | USA |
 |
Gilead Sciences
GILD
|
115 | $ 169.72 | -0.67 % | $ 211 B | USA |
 |
PhaseBio Pharmaceuticals
PHAS
|
191 | - | 7.4 % | $ 6.29 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
5.57 | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
254 | - | - | $ 8.14 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
107 | - | - | $ 26.6 B |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
389 | $ 3.86 | -5.98 % | $ 32.9 M | USA |
 |
Provention Bio
PRVB
|
19.2 | - | - | $ 2.37 B | USA |
 |
DBV Technologies S.A.
DBVT
|
71.3 | $ 11.85 | 2.95 % | $ 1.65 B |  France |
 |
Taysha Gene Therapies
TSHA
|
-37.8 | $ 4.26 | -0.35 % | $ 1.36 B | USA |
 |
Reata Pharmaceuticals
RETA
|
-5.6 | - | - | $ 6.29 B | USA |
 |
PolarityTE
PTE
|
32 | - | -0.82 % | $ 1.78 M | USA |
 |
United Therapeutics Corporation
UTHR
|
192 | $ 595.86 | 1.23 % | $ 26.4 B | USA |
 |
Vericel Corporation
VCEL
|
84.2 | $ 59.45 | 0.7 % | $ 2.99 B | USA |
 |
Veracyte
VCYT
|
29.9 | $ 25.08 | 4.24 % | $ 1.97 B | USA |
 |
Advaxis
ADXS
|
-82.3 K | - | -9.65 % | $ 45.9 M | USA |
 |
CNS Pharmaceuticals
CNSP
|
-13.6 K | $ 3.62 | -5.97 % | $ 1.6 M | USA |
 |
Trevena
TRVN
|
-412 | - | -46.58 % | $ 31.8 M | USA |
 |
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | USA |
 |
Wave Life Sciences Ltd.
WVE
|
11.5 | $ 3.42 | -0.15 % | $ 577 M |  Singapore |
 |
Exicure
XCUR
|
-4.16 | $ 1.05 | -2.78 % | $ 6.61 M | USA |
 |
Xeris Pharmaceuticals
XERS
|
535 | $ 16.51 | 4.3 % | $ 2.65 B | USA |
 |
Molecular Templates
MTEM
|
4.53 | - | -23.43 % | $ 495 K | USA |
 |
22nd Century Group
XXII
|
108 | $ 1.57 | 10.56 % | $ 289 K | USA |
 |
Zai Lab Limited
ZLAB
|
-46.6 | $ 26.42 | -0.04 % | $ 28.9 B |  China |